Uncategorized
Aura Biosciences Announces Participation at Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that members of Aura’s executive team will participate in the following upcoming investor conferences: Canaccord Genuity’s 39th Annual Growth Conference on August 8, 2019 in Boston, MA and will present at 2:00 p.m. Eastern Time BTIG Biotechnology Conference on August 12, 2019 in New York, NY About Aura Biosciences Aura Biosciences is developing a new c